BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32555469)

  • 21. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
    Stoltzfus CM
    Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.
    Brillen AL; Walotka L; Hillebrand F; Müller L; Widera M; Theiss S; Schaal H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability.
    Lützelberger M; Reinert LS; Das AT; Berkhout B; Kjems J
    J Biol Chem; 2006 Jul; 281(27):18644-51. PubMed ID: 16675444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the Virus Genome Intronic-Splicing Silencer.
    Jordan-Paiz A; Nevot M; Lamkiewicz K; Lataretu M; Franco S; Marz M; Martinez MA
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
    Stoltzfus CM; Madsen JM
    Curr HIV Res; 2006 Jan; 4(1):43-55. PubMed ID: 16454710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 splicing is controlled by local RNA structure and binding of splicing regulatory proteins at the major 5' splice site.
    Mueller N; Berkhout B; Das AT
    J Gen Virol; 2015 Jul; 96(Pt 7):1906-17. PubMed ID: 25779589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.
    Garzino-Demo A; Gallo RC; Arya SK
    Hum Gene Ther; 1995 Feb; 6(2):177-84. PubMed ID: 7734518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HIV 5' Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity.
    Grewe B; Vogt C; Horstkötter T; Tippler B; Xiao H; Müller B; Überla K; Wagner R; Asbach B; Bohne J
    Viruses; 2021 May; 13(6):. PubMed ID: 34071819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
    Sertznig H; Hillebrand F; Erkelenz S; Schaal H; Widera M
    Virology; 2018 Mar; 516():176-188. PubMed ID: 29407375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
    Purcell DF; Martin MA
    J Virol; 1993 Nov; 67(11):6365-78. PubMed ID: 8411338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    O'Reilly MM; McNally MT; Beemon KL
    Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential control of human immunodeficiency virus type 1 asp expression by alternative splicing in the upstream untranslated region.
    Barbagallo MS; Birch KE; Deacon NJ; Mosse JA
    DNA Cell Biol; 2012 Jul; 31(7):1303-13. PubMed ID: 22455394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of a cryptic splice donor in human immunodeficiency virus type-1.
    Borg KT; Favaro JP; Arrigo SJ; Schmidt M
    J Biomed Sci; 1999 Jan; 6(1):45-52. PubMed ID: 9933742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.
    Abbink TE; Berkhout B
    J Virol; 2008 Mar; 82(6):3090-8. PubMed ID: 18160437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMGA1a is involved in specific splice site regulation of human immunodeficiency virus type 1.
    Tsuruno C; Ohe K; Kuramitsu M; Kohma T; Takahama Y; Hamaguchi Y; Hamaguchi I; Okuma K
    Biochem Biophys Res Commun; 2011 Mar; 406(4):512-7. PubMed ID: 21329653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genome.
    Baeyens A; Naessens E; Van Nuffel A; Weening KE; Reilly AM; Claeys E; Trypsteen W; Vandekerckhove L; Eyckerman S; Gevaert K; Verhasselt B
    Sci Rep; 2016 Oct; 6():34573. PubMed ID: 27721439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
    Kammler S; Leurs C; Freund M; Krummheuer J; Seidel K; Tange TO; Lund MK; Kjems J; Scheid A; Schaal H
    RNA; 2001 Mar; 7(3):421-34. PubMed ID: 11333022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.